QA: Tharimmune Inc. in us_pharma/2022

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001861657_2023_Tharimmune_Inc.pdf

Logs

warning Missing logo subcommand.report {}

Graph

Absolute values for 0001861657, Tharimmune Inc.

  xvar xval
0 AssetsCurrent 6,688,628
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 0
3 remainder_Assets 0
4 LiabilitiesCurrent 1,144,973
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 4,603,514
9 ResearchAndDevelopmentExpense 2,278,424
10 remainder_Expenses 0
11 remainder_Revenues 0
12 remainder_NetIncome -1,591,244
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 6,688,628
1 Liabilities 1,144,973
2 Expenses 6,881,938
3 Revenues 0
4 StockholdersEquity 5,543,655
5 NetIncome -8,473,182
6 ComprehensiveNetIncome -8,473,182
7 BaseVar 8,153,392
8 EconomicCapitalRatio 0.271

Edgar->Model Mapping

Feature Distribution

Change over Time